Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8363 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8246 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8108 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.807 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8045 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8036 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8036 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8023 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7978 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7944 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7935 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7869 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7809 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7796 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7772 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD3749 |
Approved |
0.774 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7717 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7717 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7663 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7661 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7634 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7634 |
Intermediate Similarity |
NPD8313 |
Approved |
0.763 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7614 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7609 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7602 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7596 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7554 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7543 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7514 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5401 |
Approved |
0.75 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7474 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7471 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7463 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7463 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7424 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7424 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7416 |
Intermediate Similarity |
NPD37 |
Approved |
0.7413 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD919 |
Approved |
0.7387 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7387 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7377 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD6776 |
Approved |
0.736 |
Intermediate Similarity |
NPD6780 |
Approved |
0.736 |
Intermediate Similarity |
NPD6779 |
Approved |
0.736 |
Intermediate Similarity |
NPD6781 |
Approved |
0.736 |
Intermediate Similarity |
NPD6777 |
Approved |
0.736 |
Intermediate Similarity |
NPD6778 |
Approved |
0.736 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.73 |
Intermediate Similarity |
NPD8319 |
Approved |
0.73 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7283 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7259 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7249 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD920 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7204 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7194 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7194 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7193 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7159 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7136 |
Intermediate Similarity |
NPD8491 |
Approved |
0.7136 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7119 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7109 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD8469 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7236 |
Approved |
0.71 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7098 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7093 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7076 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7068 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7052 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7028 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7006 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.6995 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD3748 |
Approved |
0.6994 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD8435 |
Approved |
0.699 |
Remote Similarity |
NPD8360 |
Approved |
0.699 |
Remote Similarity |
NPD4287 |
Approved |
0.699 |
Remote Similarity |
NPD8361 |
Approved |
0.6989 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6941 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6931 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6914 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6912 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6893 |
Remote Similarity |
NPD7584 |
Approved |
0.6893 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7003 |
Approved |
0.6885 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6881 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD8485 |
Approved |
0.6854 |
Remote Similarity |
NPD4665 |
Approved |
0.6854 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.685 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.685 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6849 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6829 |
Remote Similarity |
NPD7680 |
Approved |
0.6825 |
Remote Similarity |
NPD7930 |
Approved |
0.6821 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6818
|
Remote Similarity |
NPD2344 |
Approved |